The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 17, 2024
Filed:
Jan. 19, 2024
Applicant:
Epics Therapeutics, Gosselies, BE;
Inventors:
Guillaume Dutheuil, Gosselies, BE;
Graeme Fraser, Gosselies, BE;
Catherine Sorlet, Gosselies, BE;
Killian Oukoloff, Gosselies, BE;
François Lenoir, Gosselies, BE;
Julien Korac, Gosselies, BE;
Assignee:
EPICS THERAPEUTICS, Gosselies, BE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 401/14 (2006.01); A61K 31/501 (2006.01); A61P 35/00 (2006.01); C07D 405/14 (2006.01); C07D 413/14 (2006.01); C07D 417/14 (2006.01); C07D 471/04 (2006.01); C07D 513/04 (2006.01);
U.S. Cl.
CPC ...
C07D 401/14 (2013.01); A61K 31/501 (2013.01); A61P 35/00 (2018.01); C07D 405/14 (2013.01); C07D 413/14 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01); C07D 513/04 (2013.01);
Abstract
Compounds of formula (I), or the pharmaceutically acceptable salts and/or the solvates thereof, wherein m, n, R, R, R, R, R, L, Arand Arare as defined as disclosed, which are useful as inhibitors of METTL3 (N6-adenosine-methlytransferase subunit) activity, in particular for the treatment of proliferative diseases such as cancers.